Printer Friendly
The Free Library
14,504,020 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Novel drug may take on lung cancer.


In several kinds of cancer, malignant cells display an excess of a specific type of surface receptor, which when stimulated causes unchecked growth of such cells (SN: 9/11/04, p. 164).

Scientists now report that a novel agent bottles up this so-called epidermal growth factor receptor This article is about a cell suface receptor. For estimated measure of kidney function (eGFR), see Glomerular filtration rate.
The epidermal growth factor receptor
 and stalls the growth of cancer cells in a lab dish. The strong results have led the researchers to begin testing the new drug, called HKI-272, in people with lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell.  that has proved resistant to two existing anticancer drugs Anticancer Drugs Definition

Anticancer, or antineoplastic, drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
 that target the same receptor, reports Daniel A. Haber of Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world  Cancer Center in Charlestown.--N.S.
COPYRIGHT 2005 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:MICROBIOLOGY; testing HKI-272 drug for lung cancer
Publication:Science News
Article Type:Brief Article
Geographic Code:1U1MA
Date:May 7, 2005
Words:106
Previous Article:Anti-inflammatories cut risk of mouth cancer.(BIOMEDICINE)(Brief Article)
Next Article:Meetings.(American Association for Cancer Research meetings )(Brief Article)
Topics:



Related Articles
Gene therapy approved for lung cancer. (k-ras and p53 approved for use by National Institutes of Health) (Brief Article)
Transplant drug increases cancer risk.(immune system suppressor cyclosporine may encourage or cause cancer)(Brief Article)
High estrogen linked to lung cancer.(Brief Article)
Active lung gene signals cancer spread.(Brief Article)
ORGANON GETS FIRST EUROPEAN MARKETING APPROVAL FOR REMERON.
CANCER TREATMENT DRAWS NOTICE; SANTA CLARITA CENTER RECEIVING NUMEROUS INQUIRIES.(News)
Is CT scanning for everyone? (Health Care Industry Spotlight).(Brief Article)
CYCLACEL'S CYC202 INDUCES CANCER CELLS TO COMMIT SUICIDE.
Targeted attack: scientists declare war on a protein implicated in some stubborn forms of cancer.(cancer research)
Agents of metastasis: four proteins conspire in breast cancer spread.(This Week)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles